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 CURRENTOPINION Emerging outcome measures for nutrition trials in
the critically ill
Danielle E. Beara,b,c,d,, David Griffithe,, and Zudin A. Puthuchearyd,f,g,
Purpose of review
Mortality has long been the gold-standard outcome measure for intensive care clinical trials. However, as
the critical care community begins to understand and accept that survivorship is associated with functional
disability and a health and socioeconomic burden, the clinical and research focus has begun to shift
towards long-term physical function
Recent findings
To use mortality as a primary outcome measure, one would either have to choose an improbable effect
(e.g. a difference of 5–10% in mortality as a result of a single intervention) or recruit a larger number of
patients, the latter being unfeasible for most critical care trials.
Outcome measures will need to match interventions. As an example, amino acids, or intermittent feeding,
can stimulate muscle protein synthesis, and so prevention of muscle wasting may seem an appropriate
outcome measure when assessing the effectiveness of these interventions. Testing the effectiveness of these
interventions requires the development of novel outcome measures that are targeted and acceptable to
patients. We describe advancements in dual-energy X-ray absorptiometry scanning, bio-impedence
analysis, MRI and muscle ultrasound in this patient group that are beginning to address this development
need.
Summary
New approaches to outcome assessment are beginning to appear in post-ICU research, which promise to
improve our understanding of nutrition and exercise interventions on skeletal muscle structure, composition
and function, without causing undue suffering to the patient.
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INTRODUCTION
Mortality has long been the gold-standard outcome
measure for intensive care clinical trials – this being
the ultimate rationale behind the use of multi-organ
support in the sickest patients [1]. However, hospital
and intensive care mortality are perhaps no longer
considered the best time points, with 90-day, 6-
month and 1-year mortality being examined [2].
Additionally, acquired morbidity following critical
illness is of increasing interest [3].
The changing face of intensive care medicine
has ramifications for clinical trial design and meth-
odology, including trials investigating nutrition
interventions. In the setting of modern critical care,
an unrefined patient population will have an ICU
mortality of 20%, rising to closer to 30% at hospital
discharge [4]. To use mortality as a primary outcome
measure, one would either have to choose an
improbable effect (e.g. a difference of 5–10% in
mortality as a result of a single intervention) or
recruit a larger number of patients, the latter being
unfeasible for most critical care trials [5]. However,
equipoise exists as to whether or not a single inter-
vention can affect mortality in a population
in which multiple physiological stressors (e.g.
inflammation, hypoxia, multi-organ failure) will
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contribute. This scenario is possibly fuelled by large
multicentre observational studies demonstrating
positive associations between single interventions,
such as nutritional delivery [6]. However, the
recently completed TARGET study (NCT02306746,
The Augmented versus Routine approach to Giving
Energy Trial) did indeed recruit a large number of
patients (4000) and may offer a potential answer
on causality.
As a result of the growing interest in survivor-
ship, critical care trials are increasingly either
embedding health-related quality of life and/or
functional outcome measures as secondary out-
comes, or using these measures as primary outcomes
[7,8]. Considering these outcomes, nutritional inter-
ventions are plausible as appropriate, effective inter-
ventions. Amino acid availability affects protein
homeostasis and thus muscle mass. Substrates for
energy production are necessary for protein homeo-
stasis and for muscle (and indeed all cells) to func-
tion [9]. Thus, nutritional interventions may indeed
affect functional and health-related outcomes by
affecting muscle mass and function, but limited data
exist to support this.
SIGNAL-TO-NOISE RATIOS
Several recent trials have incorporated measures of
muscle mass or physical or functional outcomes into
their study design, albeit mainly as secondary out-
comes or in smaller sub-studies, with varying results
[10,11
&
,12]. As an example, early goal directed nutri-
tion in ICU patients (EAT-ICU) [11
&
] aimed to inves-
tigate the effect of early goal-directed nutrition
(EGDN) over the first week of ICU stay on the
Physical Component Score (PCS) of the short form
(36) health survey at 6 months. Protein intakes
were targeted based on urinary urea nitrogen
measurements, and adjusted according to plasma
urea. No differences in the primary or secondary
outcomes were found. Such studies lead clinicians to
believe that nutrition support does not enhance
physical or functional outcomes. This may or may
not be true, but it is not clear that such studies (no
matter how well executed) contribute to this under-
standing. Long-term outcomes are affected by a
multitude of factors preceding critical illness (such
as frailty, comorbidities and socio-economic status),
and post critical illness (such as persistent inflam-
mation, new organ dysfunction and post-traumatic
stress disorders) [13
&
]. To statistically dissect out the
signal of a 5 or 10-day intervention on 6-month to 1-
year outcomes through this noise would seem chal-
lenging if not nearly impossible, regardless of the
intervention [14]. Several post-hoc analyses of phys-
ical rehabilitation trials have demonstrated the
importance of baseline correction for outcome
[15
&
] and stratification by post-critical illness biol-
ogy [16
&
] as methods to refine data for outcome
analyses.
Two newer concepts are likely to be explored in
future critical care trials. First, ‘critical illness’ is
currently being defined by time epochs – ‘acute
critical illness’, ‘chronic critical illness [17]’ and
‘post-intensive care syndrome [18]’. However, these
epochs lack markers of division where these markers
are far more likely to be biological as opposed to
merely time-based (e.g. markers of inflammation
versus days since admission). This is particularly
pertinent when considering trials of nutrition and
exercise where the biological interaction between
these interventions may be uncoupled early in criti-
cal illness [19], and are likely to only be effective
once this is re-coupled [20]. Work has begun within
the epoch between ICU discharge and hospital dis-
charge, an area with little data and where interven-
tions are far more likely to be effective as the
confounders of inflammation, hypoxia and multi-
organ failure have subsided [21,22]. We now know
that, after discharge, our patients continue through
their hospital admission not meeting energy or
protein targets [23], which is likely to have a signifi-
cant impact on outcome and needs to be accounted
for.
Second, outcome measures will need to match
interventions. As an example, amino acids, or inter-
mittent feeding, can stimulate muscle protein syn-
thesis, and so prevention of muscle wasting may
seem an appropriate outcome measure when assess-
ing the effectiveness of these interventions. For
muscle to gain mass and quality (and therefore
increase function) a combination of amino acids
and exercise is required. A functional outcome
may therefore be appropriate [24]. The difficulty
KEY POINTS
 The focus of critical care research is shifting from
survival to long-term physical function.
 Innovative nutrition interventions are likely to have a
pivotal role in maintaining neuromuscular function
during critical illness and restoring it afterwards.
 Testing the effectiveness of these interventions requires
the development of novel outcome measures that are
targeted and acceptable to patients.
 We describe advancements in DXA scanning, bio-
impedence analysis, MRI and muscle ultrasound in this
patient group that are beginning to address this
development need.
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here is that this is an emerging aspect of critical care
nutritional research, and therefore knowledge trans-
lation from other patient groups is necessary.
UNDERSTANDING METABOLIC
DYSFUNCTION IS ESSENTIAL FOR
SUCCESSFUL OUTCOME DEVELOPMENT
Much work has been done in understanding the
unique factors underpinning measurement instru-
ments of physical function in trials of rehabilitation
in critical illness [25]. An important element that
has come out of this work is the importance of
considering an instrument that matches the
intended outcome and the intervention. Much less
work has been done in the field of nutrition, and
although the importance of including physical or
functional outcomes in trials of nutrition support in
critical illness is accepted, much less is understood
about the underlying physiology of these interven-
tions how they will lead to the desired outcome [26].
It is likely that different interventions, and there-
fore, perhaps, outcome measures, will be most use-
ful at different time epochs during admission to
match the dynamic changes in physiology (Fig. 1).
Starting from admission, baseline characteristics
play an important role in the likelihood of a suc-
cessful intervention. Patients may enter the ICU
malnourished [27] or with low muscle mass [28],
with several comorbidities or of an advanced age, all
of which not only influence functional performance
and ability [7,29], but response to nutrition [30]. The
amount of muscle mass may influence requirements
for nutrients such as protein; however, current prac-
tice is to set targets based on bodyweight (actual or
ideal) as opposed to body composition (e.g. amount
of lean mass). It would not seem unreasonable to
suggest that nutrition targets should be based on the
amount muscle mass if functional outcomes are to
be measured.
Throughout the first week of ICU stay it has been
shown that muscle protein synthesis is initially
depressed to levels associated with fasted controls,
with variable recovery over the following 7 days, but
muscle protein catabolism remains raised, leading
to a net catabolic balance and the subsequent loss of
skeletal muscle [31]. New data suggest that that
muscle protein balance becomes less negative over
time, with a plateau at about day 35 [32
&&
], impor-
tantly, driven mainly by an increase in muscle pro-
tein synthesis. These data support the suggestion
that nutrition interventions should be tailored to
the time point of admission according to the physi-
ological changes that are occurring. For example,
specific amino acid metabolites, such as b-hydroxy-
b-methylbutyrate (HMB), which target catabolic
pathways [33], may be efficacious in the early phases
of ICU admission. This may be followed by admin-
istration of amino acids such as leucine, that target
the pathways of muscle protein synthesis [34], in the
latter phases of critical illness to tip the balance into
a more anabolic state.
Underpinning all of the above is the contribu-
tion of inflammation and generation of ATP. Both
inflammation and lack of ATP inhibit muscle pro-
tein synthesis, which may be a limiting factor for
FIGURE 1. Potential outcome measures and considerations which may influence outcome at each time point during critical
illness. BIA, bioelectrical impedance analysis; CT, computed tomography; DXA, dual-energy X-ray absorptiometry.
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any intervention aiming to reduce skeletal muscle
wasting and enhance physical and functional per-
formance [35
&&
]. Considering nutrition interven-
tions that modulate these, such as HMB or
inducing ketosis to provide an alternative fuel
source for ATP generation, may be warranted [9].
Lastly, the combined effect of nutrition and
exercise requires consideration [36], though imple-
mentation of this strategy is not without difficulty,
as there are several factors which may influence
functional ability including muscle endurance, fati-
gability, cognition, mental health, sleep disturbance
along with the patients’ premorbid health, age and
length of illness [7,25,29]. Nutrition strategies to
combine with different exercise regimens require
careful consideration of the mechanisms underlying
their potential effect. Data from populations outside
of critical illness may provide important insights.
For example, coupling exercise with bolus/intermit-
tent feeding to enhance the anabolic window seen
with the ‘muscle full effect’ in healthy individuals
may be one intervention worth considering.
MUSCLE MASS-BASED OUTCOME
MEASURES IN THE CRITICAL ILLNESS
SURVIVOR
Although our understanding of the physical prob-
lems faced by ICU survivors continues to increase,
the gulf in the literature between what happens to
skeletal muscle during and after acute critical illness
is significant. Although critically unwell, patients
remain within convenient proximity of the
researchers, and unpleasant procedures such as mus-
cle biopsy can be conducted under analgo-sedation
or anaesthesia, lessening the inconvenience and
discomfort experienced by the individual. Once dis-
charged to the community, follow-up is far less
complete [37]. Our understanding of what happens
to skeletal muscle after hospital discharge is often
derived indirectly from outcome measures that can
be assessed reliably by telephone interview or survey
as seen in the recent EAT-ICU trial [11
&
].
It is in smaller-scale observational studies
exploring the mechanisms of weakness and recovery
that the more proximal and organ-specific measures
can be found. Even blood sampling suffers signifi-
cantly greater attrition when compared to other
outcome measures [16
&
]. It seems unlikely that par-
ticipants who feel able to return to a healthcare
facility for detailed testing are truly representative
of a population that may also contain individuals
who, for physical or psychological reasons, cannot
attend. Unfortunately, our most detailed studies of
muscular regeneration after ICU may have so far
mainly been conducted in the fittest of ICU
survivors. New approaches to outcome assessment
are beginning to appear in post-ICU research, which
promise to improve our understanding of nutrition
and exercise interventions on skeletal muscle struc-
ture, composition and function, without causing
undue suffering to the patient.
In the sub-study of patients with acute respira-
tory distress syndrome mentioned above, Chan [38]
employed dual-energy X-ray absorptiometry (DXA)
to study body composition after ICU discharge,
participants tended to gain fat mass while maintain-
ing lean (skeletal muscle) mass. Although strength
and self-reported function were not affected by body
composition, walking speed and distance were
improved in patients who had a higher muscle-to-
fat ratio, perhaps revealing an important link
between body composition and physical function
[38].
As a nutrition outcome measure, DXA scanning
is therefore appealing. It is acceptable to patients, is
conducted with a very low dose of ionizing radiation
and provides information about both fat and muscle
mass. This latter benefit is particularly relevant to
studies of nutrition interventions where improve-
ment of lean mass, in specific preference to an
increase in fat mass, is often the goal.
A continuous improvement in the portability
and resolution of musculoskeletal ultrasound (US)
makes it attractive as a non-invasive measure of
muscle volume and quality during follow-up from
ICU, and may be the ideal modality for assessing the
impact of nutrition interventions during and after
ICU admission. Measurements of muscle mass, qual-
ity and architectural structure have been embraced
[39]. Despite a significant variation in the conduct
and reporting of these studies, and a requirement for
standardization of approaches [40,41], the emer-
gence of novel US measures, such as measures of
glycogen storage, may have relevance in the post-
ICU period, despite having limitations in the acutely
unwell patient. Surprisingly, the application of mus-
culoskeletal US in the post-ICU period has been
limited. In a 37-patient study of ICU patients with
traumatic brain injury (TBI), quadriceps muscle
layer thickness (QMLT) was assessed in the post-
ICU ward after ICU discharge and at 3 months
post-ICU discharge. Eight of the included patients
underwent DXA scanning, and in these patients,
total body lean mass was strongly associated with
QMLT, suggesting perhaps a role for post-ICU US for
assessment of muscle quality. Despite this, like
many other post-ICU studies, there was a major
attrition, with only 13 (35%) of the original sample
available for US at 3 months [27].
Body composition can be also estimated nonin-
vasively using bioelectrical impedance (BIA). In
Nutrition and physiological function
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healthy individuals, BIA can reliably estimate fat-
free mass (FFM) by applying regression equations to
measured BIA parameters. These estimates are not
accurate in patients with deranged physiology,
where fluid compartments are dynamic such as in
critical illness [42]. Raw values such as phase angle
may be useful for predicting outcome in certain
disease states, but for tracking nutrition during crit-
ical illness are unlikely to be useful, as changes may
reflect alterations in fluid status rather than nutri-
tion or muscle mass. In the post-ICU period, there
may be value in studying phase angle over time, and
if validated against a radiological measure such as
intramuscular fat fraction, may have significant
value as a marker of nutrition recovery.
Measurements of muscle cross-sectional area
and density, reflecting total body muscle mass
and quality, have been measured in diagnostic com-
puted tomography (CT) scans acquired during criti-
cal illness [39]. Low muscle mass and quality are
associated with negative outcomes, such as mortal-
ity and length of ICU treatment [39,43], but even in
the hospital setting, the drawbacks of cost, time,
transport risk and radiation exposure preclude pro-
spective evaluation. Although the transport risks in
the post-ICU patient are minimal, the other draw-
backs remain significant, and CT has not yet been
used to track muscle recovery after hospital dis-
charge. However, given the use of CT to diagnose
and monitor a significant number of other factors
which influence patient morbidity, it is perhaps not
unreasonable to begin to consider the use of in-
hospital CT scans to monitor body composition
and allow treatments to be tailored to the
individual.
Similarly, MRI provides an alternative to muscle
biopsy in the study of myopathy. In contrast to
radiological techniques, MRI can identify muscle
abnormalities within specific muscle compartments
identifying areas of oedema (normally associated
with acute processes) and lipid infiltration (nor-
mally associated with chronic process). It will also
undoubtedly be useful for delineating the precise
location of fat (intra versus extra-muscular) in body
composition studies. Although impractical in the
assessment of acutely unwell patients, its feasibility
in the post-ICU period is currently being explored
(Griffith, personal communication; trial registry
ISCTRN1782997). Whilst likely to be useful in
exploring mechanisms of muscular recovery, its
importance as an outcome measure in ICU nutrition
trials is currently limited by its cost and the unclear
relationship to physical outcomes. Further research
is required to understand whether a reduction in
oedema or an improvement in muscle quality trans-
lates into an improvement in health.
CONCLUSION
Nutritional research in critical illness continues to
evolve. To maintain clinical relevance, outcome
measures related to function and muscle mass are
likely to be increasingly important as opposed to
mortality. Newer outcomes are needed that map to
the increasingly diverse and complex interventions
seen in trials.
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